-
Topics
- All Topics
- Self Care
- Blood & Skin
- Cancer & Screening
- Cardiovascular & Respiratory
-
Children & Family
- Child Emotional Wellbeing & Mental Health
- Children, Young People & Family
- Domestic Violence & Abuse
- Female Genital Mutilation
- Gender Identity
- Homelessness
- Learning Disabilities & Neurodevelopmental Disorders
- Migrant Health
- Safeguarding Adults
- Safeguarding Children
- Sexual Health
- Social Prescribing
- Speech & Language Therapy
- Diabetes & Endocrine
- Diagnostics & Investigations
- Frailty & Complex Care
- Gastroenterology, Colorectal, Renal & Urology
- Head, Neck & Eyes
- Infectious Diseases
- Mental Health
- MSK
- Neurology & Neurosurgery
- Nutrition & Weight Management
- Obstetrics & Gynaecology
- Social Care & Safeguarding
- Urgent & Emergency
- Pathways
-
Medicines
- Community Pharmacy
- Controlled Drugs Accountable Officer
- Electronic Prescription Service
- Infections and Antibiotics
- Medicines Compliance
- Medicines Management Teams: NCL
- Medicines Optimisation Prescribing Policies
- Medicines Supply Issues
- Opioids and Dependence-forming Medications
- Patient Group Directions
- Prescribing Guidelines
- Prescribing Quality Scheme (PQS)
- Prescribing Recommendations (NPR)
- Prescribing Watch
- Self-Care Medicines Scheme (SCMS)
- Shared Care
- Fact Sheets
-
Practice Management
- Cancer Care Resources
- Deadlines
- Enhanced Services
- General Practice Access Support
- General Practice Staff Survey
- Greener NCL: Sustainable General Practice
- Hospital Bypass Contacts
- Immunisations & Vaccinations
- Interface Consensus
- Practice Vacancies
- Referral Support
- Research Opportunities
- Submit a Patient Safety Incident Report
- Submit a Quality Alert
- Support for Staff
- Veterans’ Healthcare
- Education
- Digital
- Home
- Enhanced Service
- Anticoagulation Monitoring Level 4 LCS
Anticoagulation Monitoring Level 4 LCS
IslingtonAnticoagulation Monitoring Level 4 LCS
This specification requires anticoagulation monitoring service providers in primary care to provide a level 4 service. This means providers would be responsible for sampling, testing and dosing patients on vitamin-K antagonists according to locally-agreed protocols approved by the ICB. Clinical support and advice will be provided by the Haematology Departments at the respective hospitals.
The overall aim is to provide an integrated anticoagulation service across primary and secondary care for patients on vitamin-K antagonist therapy. In particular, the enhanced service will:
- Provide increased capacity in the community to meet the rising demand for anticoagulation monitoring.
- Shift some of the burden of anticoagulation monitoring from the Whittington, UCLH, Homerton and St Bartholomew’s Hospital into the community, allowing the Haematology Department to focus on new and complex patients.
- Provide more services that are nearer to patients and are easily accessible.
- Ensure the same high quality of service to patients whether accessed in primary or secondary care.
- Ensure a consistent approach to testing, sampling and dosing between primary and secondary services.
- Ensure that maintenance of patients is properly controlled and the need for continuation of therapy is reviewed regularly and therapy is discontinued where appropriate.
- Enhance the confidence and develop the skills of GPs and community pharmacists and staff who have an interest in anticoagulation monitoring.
- Improve the primary/secondary care interface resulting in a streamlined service that benefits patients.
Specification Document
Download • PDF, 265.71 KB
Copy URL
Anticoagulation Monitoring Level 4 Service Specification (April 2024-March 2025)
NCL WideReview date: Friday, 11 July 2025